Open AccessAdvanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen
Author(s) -
Yakup Bozkaya,
Gökmen Umut Erdem,
Nuriye Özdemir,
Cemil Hocazade,
Ozan Yazıcı,
Nebi̇ Serkan Demi̇rci,
Nurullah Zengi̇n
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.184514
Subject(s) - docetaxel , medicine , regimen , mucositis , neutropenia , gastroenterology , fluorouracil , chemotherapy , signet ring cell carcinoma , nausea , febrile neutropenia , chemotherapy regimen , cisplatin , surgery , progressive disease , oncology , cancer , adenocarcinoma
The aim of this retrospective study was to investigate the clinicopathological characteristics of patients with signet-ring cell carcinoma (SRCC) of the stomach, and the efficacy of the modified docetaxel, cisplatin, and fluorouracil (mDCF) chemotherapy regimen.